Literature DB >> 2969220

Influence of oral isotretinoin treatment on the composition of comedonal lipids. Implications for comedogenesis in acne vulgaris.

B Melnik1, T Kinner, G Plewig.   

Abstract

One of the primary events in the pathogenesis of acne vulgaris is abnormal follicular keratinization. Since oral isotretinoin therapy reduces follicular hyperkeratinization in acne, our study has been designed to determine whether epidermal lipid composition of the epithelium of sebaceous follicles is affected by isotretinoin treatment. Noninflamed early comedones obtained from ten patients with nodulocystic acne before and after the 6th week of isotretinoin therapy (mean daily dose 0.7 mg/kg b. wt.) were used as probes of the hyperkeratinizing follicular epithelium. Comedonal lipids were analyzed by high-performance thin-layer chromatography. Oral isotretinoin caused a decrease of the comedonal glyceride fraction by 36% (P less than 0.01), whereas free sterols and total ceramides increased by 34% (P less than 0.10) and 19%, respectively. The changes of comedonal lipids were associated with a significant elevation of the free sterols/cholesterol sulfate ratio of 86% from pretreatment levels (P less than 0.05). The isotretinoin-induced changes of the comedonal lipid composition in direction to a pattern of epidermal lipids of normal desquamating stratum corneum are discussed as a possible comedolytic mechanism of oral isotretinoin treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969220     DOI: 10.1007/bf00417712

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  33 in total

Review 1.  An overview of acne.

Authors:  A M Kligman
Journal:  J Invest Dermatol       Date:  1974-03       Impact factor: 8.551

2.  Composition of human comedone lipids.

Authors:  L L Gershbein; J B Haeberlin; E J Singh
Journal:  Dermatologica       Date:  1970

3.  Variability in the chemical composition of human skin surface lipids.

Authors:  D T Downing; J S Strauss; P E Pochi
Journal:  J Invest Dermatol       Date:  1969-11       Impact factor: 8.551

4.  [13-cis retinoic acid in the oral therapy of acne conglobata. Results of a multi-center study].

Authors:  G Plewig; H Gollnick; W Meigel; H Wokalek
Journal:  Hautarzt       Date:  1981-12       Impact factor: 0.751

5.  The epidermal cholesterol sulfate cycle.

Authors:  E H Epstein; M L Williams; P M Elias
Journal:  J Am Acad Dermatol       Date:  1984-05       Impact factor: 11.527

6.  Changes in long-term sebum production from isotretinoin therapy.

Authors:  J S Strauss; A M Stranieri
Journal:  J Am Acad Dermatol       Date:  1982-04       Impact factor: 11.527

7.  Actions of isotretinoin and etretinate on the pilosebaceous unit.

Authors:  E C Gomez
Journal:  J Am Acad Dermatol       Date:  1982-04       Impact factor: 11.527

8.  Stratum corneum lipids in disorders of cornification. Steroid sulfatase and cholesterol sulfate in normal desquamation and the pathogenesis of recessive X-linked ichthyosis.

Authors:  P M Elias; M L Williams; M E Maloney; J A Bonifas; B E Brown; S Grayson; E H Epstein
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

9.  The treatment of severe cystic acne with 13-cis-retinoic acid. Evaluation of sebum production and the clinical response in a multiple-dose trial.

Authors:  L N Farrell; J S Strauss; A M Stranieri
Journal:  J Am Acad Dermatol       Date:  1980-12       Impact factor: 11.527

10.  Dilutional effect of increased sebaceous gland activity on the proportion of linoleic acid in sebaceous wax esters and in epidermal acylceramides.

Authors:  M E Stewart; M O Grahek; L S Cambier; P W Wertz; D T Downing
Journal:  J Invest Dermatol       Date:  1986-12       Impact factor: 8.551

View more
  8 in total

1.  Isotretinoin and FoxO1: A scientific hypothesis.

Authors:  Bodo C Melnik
Journal:  Dermatoendocrinol       Date:  2011-07-01

Review 2.  Current use and future potential role of retinoids in dermatology.

Authors:  C E Orfanos; C C Zouboulis; B Almond-Roesler; C C Geilen
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

3.  Impaired water barrier function in acne vulgaris.

Authors:  A Yamamoto; K Takenouchi; M Ito
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 4.  Transdermal penetration of topical drugs used in the treatment of acne.

Authors:  Andrea Krautheim; Harald Gollnick
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

5.  Face to face with oral isotretinoin: a closer look at the spectrum of therapeutic outcomes and why some patients need repeated courses.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-11

Review 6.  p53: key conductor of all anti-acne therapies.

Authors:  Bodo C Melnik
Journal:  J Transl Med       Date:  2017-09-19       Impact factor: 5.531

7.  Challenges and Solutions in Oral Isotretinoin in Acne: Reflections on 35 Years of Experience.

Authors:  Vincenzo Bettoli; Aurora Guerra-Tapia; Maria Isabel Herane; Jaime Piquero-Martín
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-12-30

8.  Comparative study of oral isotretinoin versus oral isotretinoin + 20% salicylic Acid peel in the treatment of active acne.

Authors:  Bikash Ranjan Kar; Sanjita Tripathy; Maitreyee Panda
Journal:  J Cutan Aesthet Surg       Date:  2013-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.